| NCT Number | NCT07488156 |
| Lead Sponsor | Louisiana State University Health Sciences Center in New Orleans
Collaborators: Janssen Pharmaceuticals |
| Conditions | Schizophrenia Disorder, Schizoaffective Disorder, Psychosis |
| Enrollment | 34 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2027-07-30 (estimated) |
| Study Completion | 2028-01-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-23 |